{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:16:38Z","timestamp":1787224598483,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003486","name":"Hellenic Rheumatology Society","doi-asserted-by":"publisher","award":["ERE141\/10"],"award-info":[{"award-number":["ERE141\/10"]}],"id":[{"id":"10.13039\/501100003486","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Propondis Foundation"},{"DOI":"10.13039\/501100003447","name":"State Scholarships Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lillian Voudouri Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaut.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T11:01:10Z","timestamp":1507978870000},"page":"62-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Impaired anti-inflammatory activity of PPAR\u03b3 in the salivary epithelia of Sj\u00f6gren's syndrome patients imposed by intrinsic NF-\u03baB activation"],"prefix":"10.1016","volume":"86","author":[{"given":"Aigli G.","family":"Vakrakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia K.","family":"Kapsogeorgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menelaos N.","family":"Manoussakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.09.007_bib1","first-page":"191","article-title":"Sjogren's syndrome: current concepts","volume":"47","author":"Manoussakis","year":"2001","journal-title":"Adv. Intern. Med."},{"key":"10.1016\/j.jaut.2017.09.007_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.01.013","article-title":"Classification criteria of Sjogren's syndrome","volume":"48\u201349","author":"Goules","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.09.007_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.09.007_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12016-007-8007-4","article-title":"The role of epithelial cells in the pathogenesis of Sjogren's syndrome","volume":"32","author":"Manoussakis","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2362.2008.02022.x","article-title":"Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma","volume":"38","author":"Varga","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jaut.2017.09.007_bib6","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1021\/cr2001355","article-title":"PPARs and lipid ligands in inflammation and metabolism","volume":"111","author":"Harmon","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jaut.2017.09.007_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","article-title":"PPARs: fatty acid sensors controlling metabolism","volume":"23","author":"Poulsen","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2017.09.007_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPARgamma signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.09.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v23.i12.10","article-title":"Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses","volume":"23","author":"Nencioni","year":"2003","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/gut.2005.081745","article-title":"Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease","volume":"55","author":"Adachi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2017.09.007_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2005.06.029","article-title":"Molecular determinants of crosstalk between nuclear receptors and toll-like receptors","volume":"122","author":"Ogawa","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2017.09.007_bib13","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1074\/jbc.M110.149823","article-title":"Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter","volume":"286","author":"Zhao","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.09.007_bib14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.20705","article-title":"Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis","volume":"41","author":"Harada","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2017.09.007_bib15","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1074\/jbc.M113.536805","article-title":"Down-regulated peroxisome proliferator-activated receptor gamma (PPARgamma) in lung epithelial cells promotes a PPARgamma agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)","volume":"289","author":"Lakshmi","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.09.007_bib16","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.175.8.4948","article-title":"Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients","volume":"175","author":"Klotz","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaut.2010.06.010","article-title":"Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.09.007_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2249.2006.03311.x","article-title":"Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome","volume":"147","author":"Spachidou","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2017.09.007_bib20","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.28000","article-title":"Stimulation of nuclear receptor peroxisome proliferator-activated receptor-gamma limits NF-kappaB-dependent inflammation in mouse cystic fibrosis biliary epithelium","volume":"62","author":"Scirpo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2017.09.007_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10735-013-9487-6","article-title":"Salivary gland expression level of IkappaBalpha regulatory protein in Sjogren's syndrome","volume":"44","author":"Sisto","year":"2013","journal-title":"J.\u00a0Mol. Histol."},{"key":"10.1016\/j.jaut.2017.09.007_bib23","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/me.2007-0454","article-title":"Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation","volume":"22","author":"Park","year":"2008","journal-title":"Mol. Endocrinol. Baltim. Md"},{"key":"10.1016\/j.jaut.2017.09.007_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1874312901206010103","article-title":"Regulation of matrix remodeling by peroxisome proliferator-activated receptor-gamma: a novel link between metabolism and fibrogenesis","volume":"6","author":"Wei","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.jaut.2017.09.007_bib25","doi-asserted-by":"crossref","first-page":"148687","DOI":"10.1155\/2008\/148687","article-title":"Pathophysiological roles of PPARgamma in gastrointestinal epithelial cells","volume":"2008","author":"Necela","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.jaut.2017.09.007_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbalip.2007.02.005","article-title":"PPARgamma in immunity and inflammation: cell types and diseases","volume":"1771","author":"Szeles","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2017.09.007_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/jid.2008.369","article-title":"Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia","volume":"129","author":"Karnik","year":"2009","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.jaut.2017.09.007_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/annrheumdis-2014-205743","article-title":"PPARgamma deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage","volume":"74","author":"Vasheghani","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.09.007_bib29","first-page":"4886","article-title":"Anti-inflammatory effect of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on non-obese diabetic mice with Sjogren's syndrome","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jaut.2017.09.007_bib30","doi-asserted-by":"crossref","first-page":"453120","DOI":"10.1155\/2008\/453120","article-title":"Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR-gamma agonists","volume":"2008","author":"Gurley","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.jaut.2017.09.007_bib31","first-page":"6831","article-title":"Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells","volume":"169","author":"Schlezinger","year":"2002","journal-title":"J.\u00a0Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.jaut.2017.09.007_bib32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPARgamma is an E3 ligase that induces the degradation of NFkappaB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2017.09.007_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2017.09.007_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2003-0304RC","article-title":"Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis","volume":"30","author":"DA1","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2017.09.007_bib35","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.10001","article-title":"Post-translational modifications of nuclear receptors and human disease","volume":"10","author":"Anbalagan","year":"2012","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.jaut.2017.09.007_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3349\/ymj.2013.54.3.545","article-title":"Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications","volume":"54","author":"Kim","year":"2013","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jaut.2017.09.007_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/oby.2008.473","article-title":"Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator","volume":"17","author":"van Beekum","year":"2009","journal-title":"Obesity (Silver Spring, Md)"},{"key":"10.1016\/j.jaut.2017.09.007_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.reuma.2009.10.009","article-title":"Primary Sjogren's syndrome: expression of NF-kappaB in minor salivary glands","volume":"6","author":"Villalon","year":"2010","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.jaut.2017.09.007_bib39","first-page":"534648","article-title":"Local and systemic IKKepsilon and NF-kappaB signaling associated with Sjogren's syndrome immunopathogenesis","volume":"2015","author":"Chen","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.jaut.2017.09.007_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00418-011-0821-3","article-title":"A\u00a0failure of TNFAIP3 negative regulation maintains sustained NF-kappaB activation in Sjogren's syndrome","volume":"135","author":"Sisto","year":"2011","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.jaut.2017.09.007_bib41","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI13202","article-title":"Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis","volume":"108","author":"Setoguchi","year":"2001","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jaut.2017.09.007_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2012.11.016","article-title":"Enhanced apoptosis by disruption of the STAT3-IkappaB-zeta signaling pathway in epithelial cells induces Sjogren's syndrome-like autoimmune disease","volume":"38","author":"Okuma","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2017.09.007_bib43","doi-asserted-by":"crossref","first-page":"15193","DOI":"10.1073\/pnas.1005533107","article-title":"Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter","volume":"107","author":"Peng","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2017.09.007_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ni.1905","article-title":"Epithelial decision makers: in search of the 'epimmunome'","volume":"11","author":"Swamy","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.09.007_bib45","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2353\/ajpath.2010.100227","article-title":"Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjogren's syndrome","volume":"177","author":"Chen","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.09.007_bib46","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/art.21969","article-title":"Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome","volume":"54","author":"Ek","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.09.007_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.exer.2005.07.009","article-title":"Pathological keratinisation in the conjunctival epithelium of Sjogren's syndrome","volume":"82","author":"Hirai","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jaut.2017.09.007_bib48","first-page":"715","article-title":"Elevated IL-1beta levels in anti-Ro\/SSA connective tissue diseases patients with prolonged corrected QTc interval","volume":"33","author":"Pisoni","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.09.007_bib49","first-page":"1957","article-title":"Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease","volume":"19","author":"Vijmasi","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jaut.2017.09.007_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/14728222.2013.754427","article-title":"Targeting IL-1 in Sjogren's syndrome","volume":"17","author":"Yamada","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jaut.2017.09.007_bib51","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/art.39204","article-title":"Molecular subsetting of interferon pathways in Sj\u00f6gren's syndrome","volume":"67","author":"Hall","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.09.007_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.09.007_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sj\u04e7gren syndrome","volume":"14","author":"Papageorgiou","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.09.007_bib54","series-title":"Efficacy and Safety of Biological DMARDs Modulating B Cells in Primary Sj\u00f6gren's Syndrome: Systematic Review and Meta-analysis","author":"Letaief","year":"2017"},{"key":"10.1016\/j.jaut.2017.09.007_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sj\u00f6gren's syndrome\u2013a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.09.007_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0722.2002.00152.x","article-title":"Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells","volume":"110","author":"Dimitriou","year":"2002","journal-title":"Eur. J. Oral Sci."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117303931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117303931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:16:15Z","timestamp":1760256975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117303931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":56,"alternative-id":["S0896841117303931"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.09.007","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired anti-inflammatory activity of PPAR\u03b3 in the salivary epithelia of Sj\u00f6gren's syndrome patients imposed by intrinsic NF-\u03baB activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}